IL40433A - De a-steroids and their manufacture - Google Patents
De a-steroids and their manufactureInfo
- Publication number
- IL40433A IL40433A IL40433A IL4043372A IL40433A IL 40433 A IL40433 A IL 40433A IL 40433 A IL40433 A IL 40433A IL 4043372 A IL4043372 A IL 4043372A IL 40433 A IL40433 A IL 40433A
- Authority
- IL
- Israel
- Prior art keywords
- methyl
- dea
- dimethyl
- butoxy
- tert
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/385—Saturated compounds containing a keto group being part of a ring
- C07C49/417—Saturated compounds containing a keto group being part of a ring polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/16—Benz[e]indenes; Hydrogenated benz[e]indenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
1374850 De-A-steroids, 4,5-secosteroids F HOFFMANN-LA ROCHE & CO AG 10 Nov 1972 [12 Nov 1971] 52027/72 Heading C2C The invention relates to compounds of formula wherein R<SP>1</SP> is 3-oxobutyl, ketalized 3-oxobutyl, 3-chloro-2-butenyl, 3-methyl-2-butenyl, 3- (C 1 -C 6 alkoxy)-2-butenyl, 3-hydroxybutyl (or an ester or ether thereof), 2-carboxyethyl, 2-cyanoethyl, 2-(C 2 -C 6 alkoxycarbonyl)-ethyl or a 4-isoxazolylmethyl group bearing a C 1 -C 6 alkyl substituent in at least one of positions 3 and 5; and D is a group of formula wherein m is 1 or 2; R<SP>2</SP> is free, esterified or etherified hydroxy; R<SP>3</SP> is H, C 1 -C 6 alkyl or C 2 -C 6 alkynyl; or R<SP>2</SP> and R<SP>3</SP> together represent a ketal, ethylidene, 1-(C 1 -C 6 alkanoyloxy)- ethylidene or bis-(methylenedioxy)ethyl group; R<SP>4</SP> is H or OH; R<SP>5</SP> is oxo, ketal, (H, OH), (H, esterified OH) or (H, etherified OH); R<SP>6</SP> is H or free, esterified or etherified OH; or R<SP>4</SP> and R<SP>6</SP> may together represent C 1 -C 6 alkylidenedioxy when R<SP>5</SP> is oxo; and R<SP>7</SP> is H or Me. The invention comprises (A) compounds I (with the exception of those in which, simultaneously, m is 1; R<SP>1</SP> is 3-oxobutyl, ketalized 3-oxobutyl or 3-chloro-2-butenyl; R<SP>2</SP> is esterified hydroxy; and R<SP>3</SP> is H); and (B) the preparation of compounds I by methylating the corresponding #<SP>9(10)</SP>-10-demethyl compounds (steroid numbering) below - 50‹ C. The minor proportion of 10x-methyl epimer also formed may be removed from the 10#-methyl product by chromatography. Any ketal groups in the product may be hydrolysed.
[GB1374850A]
Claims (14)
1. A process for the manufacture of ΙΟβ-methyl deA-st wherein R represents a ketalized 3-oxobutyl group or (3 , 5-dimethyl-4-isoxazolyl)-methyl and R 2 is lower alkoxy or 1-acetoxyethyl, ' ' which process comprises treating a deA-steroid of the general wherein R and R have the significance given earlier in this claim, . at a temperature below -50°C with a methylation. agent.
2. A process according to claim 1, wherein the treatment is carried out at -70°C to -110°C.
3. ) A process according to claim 1 or claim 2, wherein the treatment is carried out using a methyl halide and a base.
4. ) A process according to claim 3, wherein said methyl halide is methyl iodide and said base is sodium hydride.
5. ) A process according to any one of claims 1 to inclusive, wherein there is used a deA-steroid starting material of formula II in which the ketal group is ethylen.ediox , 1,2-phenylenediox , 2 , 2-dimethyl-l , 3-propylenedioxy , . ,1 > 4- (2-butenyl-ene)-dioxy and 2,2-pentamethylene-lj3-propylenedioxy.
6. ) A process for the manufacture of the lO -methyl-^^11^--deA-steroids of formula I given in claim 1, substantially as hereinbefore described with reference to the foregoing Examples.
7. ) 10P-Mehtyl-A9^i:L^-deA-steroids, when manufactured by the process claimed in any one of claims 1 to 6 inclusive or by an obvious chemical equivalent thereof.
8. ) ΙΟβ-Methyl- ^i:L^-deA-steroids of the formula wherein R represents a ketalized 3-oxobutyl group or (3 ,5-dimethyl-4-isoxazolyl)-methyl and 2 R is lower alkoxy or 1-acetox ethyl.
9. ) 17 -tert.-Butoxy-10a-[ (3, 5-dimethyl-4-isoxazolyl) -methyl]- - - - - - -
10. )' 20P-Acetoxy-10a-[ (3,5-dimethyl-4-isoxazolyl)-Kiethyl]- -deA-pregn-9(ll)-en-5-one.
11. ) 17 -tertButoxy'r-,5-seco-androst-9(ll)-ene-3 ,5-dione.
12. ) 3,3-(2,2-Dimethyl-l,3-propylenedioxy)-17 -tert.-"butoxy-4, 5-secoandrost-9(ll)-en-5-one .
13. ) 3,3-[l,4-(2-Butenylene)-dioxy]-17 -tert.-butoxy-4, 5-secoandrost-9(ll) -en-5-one.
14. ) 17P-tert .-Butoxy-3 , 3-( o-phenylenediox ) -4 , 5-secoand'rost--9(ll)-en-5-one . 15 ) 17 -tert .-Butoxy-3 , 3-(2 , 2-pentamethylene-l , 3-propyl-enediox )-4 , 5-secoandrost-9(ll) -en-5-one . :OHN AND PARTNERS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH1651671A CH586174A5 (en) | 1971-11-12 | 1971-11-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL40433A0 IL40433A0 (en) | 1972-11-28 |
IL40433A true IL40433A (en) | 1976-05-31 |
Family
ID=4418045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL40433A IL40433A (en) | 1971-11-12 | 1972-09-25 | De a-steroids and their manufacture |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS4857964A (en) |
AT (1) | AT323908B (en) |
AU (1) | AU465178B2 (en) |
BE (1) | BE791184A (en) |
CH (1) | CH586174A5 (en) |
DE (1) | DE2250426A1 (en) |
FR (1) | FR2160178A5 (en) |
GB (1) | GB1374850A (en) |
IL (1) | IL40433A (en) |
NL (1) | NL7213810A (en) |
SE (2) | SE386451B (en) |
ZA (1) | ZA726400B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2500440A1 (en) * | 1981-02-23 | 1982-08-27 | Roussel Uclaf | NEW MEDICAMENTS DERIVED FROM 3-HYDROXY DODECAHYDRO BENZ (E) INDEN-7-ONE DISUBSTITUTED IN POSITION 6, PRODUCTS DERIVED FROM 3-HYDROXY DODECAHYDRO BENZ (E) INDEN-7-ONE DISUBSTITUTED IN POSITION 6, AND PROCESS FOR THEIR PREPARATION AND INTERMEDIATE PRODUCTS |
-
0
- BE BE791184D patent/BE791184A/en unknown
-
1971
- 1971-11-12 CH CH1651671A patent/CH586174A5/xx not_active IP Right Cessation
-
1972
- 1972-09-19 ZA ZA726400A patent/ZA726400B/en unknown
- 1972-09-21 AU AU46954/72A patent/AU465178B2/en not_active Expired
- 1972-09-25 IL IL40433A patent/IL40433A/en unknown
- 1972-10-12 NL NL7213810A patent/NL7213810A/xx not_active Application Discontinuation
- 1972-10-13 DE DE2250426A patent/DE2250426A1/en not_active Ceased
- 1972-11-06 JP JP47110379A patent/JPS4857964A/ja active Pending
- 1972-11-10 SE SE7214662A patent/SE386451B/en unknown
- 1972-11-10 GB GB5202772A patent/GB1374850A/en not_active Expired
- 1972-11-10 FR FR7239954A patent/FR2160178A5/fr not_active Expired
- 1972-11-10 AT AT957372A patent/AT323908B/en not_active IP Right Cessation
-
1975
- 1975-10-27 SE SE7512007A patent/SE7512007L/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE2250426A1 (en) | 1973-05-17 |
AU465178B2 (en) | 1975-09-18 |
AT323908B (en) | 1975-08-11 |
BE791184A (en) | 1973-05-10 |
NL7213810A (en) | 1973-05-15 |
GB1374850A (en) | 1974-11-20 |
JPS4857964A (en) | 1973-08-14 |
FR2160178A5 (en) | 1973-06-22 |
SE386451B (en) | 1976-08-09 |
ZA726400B (en) | 1973-07-25 |
SE7512007L (en) | 1975-10-27 |
AU4695472A (en) | 1974-03-28 |
IL40433A0 (en) | 1972-11-28 |
CH586174A5 (en) | 1977-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5559180A (en) | 4-hydroxy-2-pyrone ring compound, its preparation, and remedy for hyperlipemia comprising it as active constituent | |
IE34511B1 (en) | Heterocyclic ethers of-1-substituted-4-hydroxyalkyl piperazines and process for preparing them | |
HUP9802408A2 (en) | Naphthyl and dihydronaphthyl-derivatives, and pharmaceutical compositions, containing them | |
KR850003533A (en) | Method for preparing 1,3-dioxane derivative | |
GB1459564A (en) | Alkylphenyl benzopyrans | |
GB1298218A (en) | NOVEL BEZ[e]INDENE AND PHENANTHRENE DERIVATIVES | |
IL40433A (en) | De a-steroids and their manufacture | |
KR900003192A (en) | Antidiabetic phosphonate and preparation method thereof | |
DE69327717T2 (en) | METHOD FOR PRODUCING ALPHA, BETA-UNSATURATED KETONES | |
JPS5466695A (en) | Azetidinone derivative and its preparation | |
GB1110759A (en) | Oestrogenically active steroids and a process for their manufacture | |
AKIYAMA et al. | Chemical Studies on the Oriental Plant Drugs. XXXI. Sapogenins of the Roots of Platycodon grandiflorum A. DE CANDOLLE.(2). Structure of Platycodigenin | |
GB1439898A (en) | Method of preparing substituted cephalosporins and penicillins | |
GB1358203A (en) | Derivatives of diphenyl alkanols | |
US3740390A (en) | Cardenolide rhamnosides | |
US3828062A (en) | Process for the preparation of des a-9beta-steroids | |
JPH0222071B2 (en) | ||
GB1289966A (en) | ||
ES396825A1 (en) | Selected 5-substituted-5-phenylalkyl barbituric acids analgetic compositions and method based thereon | |
KR810001248B1 (en) | Process for preparing lactones derived form cyclopentanol | |
GB2137985A (en) | Phenylacetic acid esters | |
GB1384024A (en) | Process for the preparation of 3-hydroxy-2-3-hydroxy-1-octenyl- 5-oxocyclopentane-heptanoic acid and derivatives thereof | |
US4087436A (en) | Methylation of de-A steroids | |
KR830001893A (en) | Method for preparing 1-benzyl-1,2,5,6-tetrahydro pyridine-3-carboxylic acid derivative | |
IE37846B1 (en) | Process for preparing 6-alkoxypenicillanic and 7-alkoxycephalosporin acids |